Conventional tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), do not have high sensitivity and specificity for predicting recurrence [8,9,10,11]. This evidence concerns the gene CEACAM5 and neoplasm.